Blind monitors or greedy sponsors? [GxP / QC / QA]

posted by Ohlbe – France, 2022-05-24 16:21 (193 d 14:41 ago) – Posting: # 23014
Views: 1,566

Dear Helmut,

❝ also interesting the list of medicines concerned by the procedure. You can read it ‘backwards’, i.e., look at the sponsors.


Well, marketing authorisation holders / applicants were not necessarily the sponsor of the study. Some of them just bought the dossier off the shelf, before or after the marketing authorisation was granted. Due diligence: generally, nil, especially if the marketing authorisation was already granted. EMA organised a workshop with representatives of the generic drug industry some years ago, after the first referrals of this type. Nothing came out of it. Industry's position: "we can't audit the study when we buy the dossier coz' we were not the sponsor". It went nowhere.

❝ Given that, were monitors of the other sponsors :blind: or just greedy?


Or just incompetent ? Or were some of the sponsors perfectly aware of the scam, and willing to use such CROs precisely because they were sure their study would pass ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,427 posts in 4,694 threads, 1,598 registered users;
14 visitors (1 registered, 13 guests [including 5 identified bots]).
Forum time: 06:02 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5